Browse > Article

A Nucleic Acid Amplification Tests for Reliable HCV RNA Detection Method for Plasma-Derived Products  

Hong, Seung-Hee (Korea Human Resource Development Institute for Health and Welfare)
Publication Information
Korean Journal of Microbiology / v.44, no.4, 2008 , pp. 293-298 More about this Journal
Abstract
HCV is transmitted via various plasma derived products. Current methods to detect hepatitis C virus (HCV) are based on its antibody detection in the donated blood and plasma. Viral contamination can potentially escape such detection during the window period of infection, when no antibody is present or the level of antibody is too low to detect. It is trying to application of nucleic acid amplification tests (NAT) for the direct detection of HCV. The objective of this study was to develop a reliable NAT for the HCV RNA detection from plasma-derived products. The most useful primers was selected for NAT among 5 sets of primers. We have also found that QIAamp viral RNA isolation kit was the most efficient for HCV RNA isolation. The highest sensitivity and specificity was appeared in $48^{\circ}C$ annealing temperature and 30 pmol of primers. With a spiking of HCV to albumin, immunoglobulins and coagulation factors, NAT can detect up to 100 IU/ml. Meanwhile, COBAS amplicor HCV 2.0 afforded a lower sensitivity in high concentrated intramuscular immunoglobulins to below 500 IU/ml. Our results suggested that NAT appears to be a highly sensitive and specific method for HCV RNA detection in plasma-derived products.
Keywords
Hepatitis C virus; Nucleic acid Amplification Tests (NAT); plasma-derived products;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Christopher, J., N.K. Healiy, J.D. Sabharwal, D. Fiona, Y. Pen-Lee, A.F. Kenneth, W.G. Roger, P.S. Chapman, and H. Chapel. 1996. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screened intravenous immunoglobulin therapy. Gastroenterology 110, 1120-1126   DOI   ScienceOn
2 Fanson, B.G., P. Osmack, and A.M. Bisceglie. 2000. A comparison between the phenol-chloroform method of RNA extraction and the QIAamp viral RNA kit in the extraction of hepatitis C and GB virus-C/hepatitis G viral RNA from serum. J. Virol. Meth. 89, 23-27   DOI   ScienceOn
3 Hsiang, J.L., S. Naiyi, M. Masashi, and F.B. Hollinger. 1992. Polymerase chain reaction assay for Hepatitis C virus RNA using a single tube for reverse ranscription and serial rounds of amplification with nested primer pairs. J. Med. Virol. 38, 220-225   DOI   ScienceOn
4 Lee, D.S., Y.C. Sung, and Y.S. Whang. 1996. Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea. J. Med. Virol. 49, 55-60   DOI   ScienceOn
5 Sayah, N., M. Freddie, and B. Robin. 1994. Simultaneous amplification and detection of specific Hepatitis B virus and Hepatitis C virus genomic sequences in serum samples. J. Med. Virol. 42, 212-216   DOI   ScienceOn
6 Waleed, A.A., J.J. Leif, and R. Peter. 2000. Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR. J. Clin. Microbiol. 38, 345-350   PUBMED
7 Wilson, I.G. 1997. Inhibition and facilitation of nucleic acid amplification. Appl. Environ. Microbiol. 63, 3741-3751   PUBMED
8 Heermann, K.H., H. Seitz, and R. Thomssen. 1996. Capture and RT-PCR of hepatitis C virus RNA with safety primers. J. Virol. Meth. 59, 33-43   DOI   ScienceOn
9 Echevarria, J.M., P. Len, C.J. Domingo, J.A. Lpez, C. Elola, M. Madurga, F. Salmern, P.L. Yap, J. Daub, and P. Simmonds. 1996. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain. Transfusion 36, 725-730   DOI   ScienceOn
10 Bukh, J., R.H. Purcell, and R.H. Miller. 1992. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc. Natl. Acad. Sci. USA 89, 187-191
11 James, L.G. and D. Elizabeth. 2000. Blood screening by nucleic acid amplification technology : Current issues, future challenges. Mol. Diagn. 5, 11-22   DOI
12 Houghton, M., K. Richman, J. Han, K. Berger, C. Lee, C. Dong, L. Overby, A. Weiner, D. Bradley, G. Kuo, and Q.L. Choo. 1991. Hepatis C virus (HCV): A relative of the pestiviruses and flaviviruses, p. 328-333. In F.B. Hollinger, S.N. Lemon, and H. Margolis (eds.), Viral Hepatitis and Liver Disease. The Williams & Wilkins Co., Baltimore, Mayland, USA
13 Chandra, S., J.E. Cavanaugh, C.M. Lin, C. Pierre-Jerome, N. Yerram, R. Week, E. lanigan, and F. Feldamn. 1999. Virus reduction in the preparation of intravenous immune globullin: in vitro experiments. Transfusion 39, 249-257   DOI   ScienceOn
14 Petrik, J., G.J. Pearson, and J.P. Allain. 1997. High throughput PCR detection of HCV based on semiautomated multisample RNA capture. J. Virol. Meth. 64, 147-159   DOI   ScienceOn
15 Widell, A., Y.Y. Zhang, B. Anderson-Gre, and L. Hammarstrm. 1997. At least three hepatitis C virus strains implicated in Swedish and Danish patients with intravenous immunoglobulin-associated hepatitis C. Transfusion 37, 313-320   DOI   ScienceOn
16 Choo, Q.L., G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362   DOI